Digestive System Channel
Topics
Medications
Quicklinks
Related Channels

Thyroid Dysfunction Following Sunitinib

One of the risks associated with the chemotherapy drug sunitinib (SUTENT®) is thyroid dysfunction. Sunitinib can cause an underactive or overactive thyroid during treatment. In most cases, this dysfunction that occurs with sunitinib is reversible following treatment. To help ensure your safety, your healthcare provider will monitor your thyroid function with a blood test before you start the medication and observe you closely for problems while you are taking it.
 
(For more information, click Warnings and Precautions With Sunitinib. This article gives a more in-depth description of the safety warnings associated with this drug, including information on what to discuss with your healthcare provider and who should avoid it altogether.)
 
5 Easy Tips to Manage Visitors During Cancer Treatment
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.